Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Consolidated Net Profit

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Consolidated Net Profit ₹25 Cr₹20 Cr₹20 Cr₹1,053,410 Cr₹10 Cr

What is the latest Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) ?

The latest Consolidated Net Profit ratio of SYNCOM FORMULATIONS (INDIA) is ₹25 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹25 Cr
Mar2024₹20 Cr
Mar2023₹20 Cr
Mar2022₹1,053,410 Cr
Mar2017₹10 Cr

How is Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹25 Cr
26.12
Mar2024 ₹20 Cr
1.42
Mar2023 ₹20 Cr
-100.00
Mar2022 ₹1,053,410 Cr
10,171,878.56
Mar2017 ₹10 Cr -

Compare Consolidated Net Profit of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,348.0 Cr 5.6% 18.7% -14.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr 1.2% -7% 2.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 1.8% 2.7% 17% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 0.5% -4.8% 32.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.3% -4.5% 11.5% Stock Analytics
CIPLA ₹100,028.0 Cr 0.7% -5.8% -13.1% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

5.6%

18.7%

-14.6%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses